Luminor
Paclitaxel eluting PTA balloon dilatation catheter
The DCB you need
PRODUCT FEATURES
Easy navigation
Small profiles
Short deflation times and wide size range (0.014”, 0.018” and 0.035” guidewire compatibilities)
Coating technology matters
Not all DCBs are the same
TransferTech, the iVascular proprietary nanotechnology that:
Has an ultrathin coating thanks to the nanodrop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology, with minimum drug loss during navigation.
Ensures a uniform artery treatment
CLINICAL SUPPORT
Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:
EffPac Trial
Multicenter, randomized and controlled trial, Luminor vs POBA.
at 5 years
TINTIN Trial
Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions.
at 4 years
MERLION Trial
Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK.
at 1-year
CLINICAL SUPPORT
Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:
EffPac Trial
3.5 years outcomes presented at LINC 2021
TINTIN Trial
2-year outcomes presented at LINC 2021
Speak to the team
Our office is open Monday – Friday 8.30am – 5.00pm
Feel free to get in touch direct or leave us a message on the contact form and the team will get back to you